Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
Lipoprotein (a) [Lp(a)] is a risk factor for coronary artery disease (CAD) and its related phenotypes.
Lipoprotein (a) [Lp(a)] is a risk factor for coronary artery disease (CAD) and its related phenotypes.
Even though the prognosis after myocardial infarction (MI) has improved much over recent decades due to improved and faster revascularization, platelet inhibition, and device therapy, a proportion of post-acute MI (AMI) patients with additional risk factors remain at high risk, with 5-year mortality ranging from 15% to 45% depending on the population.
Lipid abnormalities are associated with an increased risk of CV events including coronary heart disease (CHD), thereby serving as contributors to this process.
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with approximately 3% of prevalence in adults, which enhances additionally with advancing age.
Coronary CT angiography (CCTA) is well-validated as an initial test in patients without known coronary artery disease (CAD) presenting with acute and stable chest pain.